BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Mediterr J Hematol Infect Dis 2016, 8, e2016011. https://doi.org/10.4084/mjhid.2016.011.